The treatment of basal cell carcinoma

References

• Miller D L., Weinstock M A. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774–8
   PubMed Web of Science ®Google Scholar
• Lo J S., Snow S N., Reizner G T., et al. Metastatic basal cell carcinoma: report of twelve cases with review of the literature. J Am Acad Dermatol 1991; 24: 715–19
   PubMed Web of Science ®Google Scholar
• Preston D S., Stern R S. Nonmelanoma cancers of the skin. N Engl J Med 1992; 327: 1649–62
   PubMed Web of Science ®Google Scholar
• Roenigk R K., Ratz J L., Bailin P L., et al. Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol 1986; 12: 860–5
   PubMedGoogle Scholar
• Emmett A JJ. Surgical analysis and biological behaviour of 2277 basal cell carcinomas. Aust NZ J Surg 1990; 60: 855–63
   PubMedGoogle Scholar
• Motley R J., Gould D J., Douglas W S., et al. Treatment of basal cell carcinoma by dermatologists in the United Kingdom. Br J Dermatol 1995; 132: 437–440
   PubMed Web of Science ®Google Scholar
• Ko C B., Walton S, Keczkes K, et al. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130: 269–72
   PubMed Web of Science ®Google Scholar
• Harris D WS, Benton E C., Hunter J AA. The changing face of dermatology out-patient referrals in the south-east of Scotland. Br J Dermatol 1990; 123: 745–50
   PubMed Web of Science ®Google Scholar
• Holt P JA, Motley R J. The treatment of basal cell carcinoma. Curr Pract Surg 1994; 6: 98–101
   Google Scholar
• Ashby M A., Smith J, Ainslie J, et al. Treatment of nonmelanoma skin cancer at a large Australian center. Cancer 1989; 63: 1863–71
   PubMed Web of Science ®Google Scholar
• Wolf D J., Zitelli J A. Surgical margins for basal cell carcinoma. Arch Dermatol 1987; 123: 340–4
   PubMedGoogle Scholar
• Johnson T M., Tromovitch T A., Swanson N A. Combined curettage and excision: a treatment method for primary basal cell carcinoma. J Am Acad Dermatol 1991; 24: 613–17
   PubMed Web of Science ®Google Scholar
• Rapini R P. Comparison of methods for checking surgical margins. J Am Acad Dermatol 1990; 23: 288–94
   PubMed Web of Science ®Google Scholar
• Abide J M., Nahai F, Bennett R G. The meaning of surgical margins. Plast Reconstr Surg 1984; 73: 492–6
   PubMed Web of Science ®Google Scholar
• Motley R J., Holt P JA. Micrographic surgery for basal cell carcinoma. Br J Hosp Med 1994; 52: 353–5
   PubMed Web of Science ®Google Scholar
• Wentzell J M., Robinson J K. Embryologic fusion planes and the spread of cutaneous carcinoma: a review and reassessment. J Dermatol Surg Oncol 1990; 16: 1000–6
   PubMedGoogle Scholar
• Robinson J K. What are adequate treatment and follow-up care for nonmelanoma cutaneous cancer?. Arch Dermatol 1987; 123: 331–3
   PubMedGoogle Scholar
• Emmett A JJ, Broadbent G G. Basal cell carcinoma in Queensland. Aust NZ J Surg 1981; 51: 576–90
   PubMedGoogle Scholar
• Dellon A L., DeSilva S, Conolly M, et al. Prediction of recurrence of incompletely excised basal cell carcinoma. Plast Reconstr Surg 1985; 75: 860–71
   PubMed Web of Science ®Google Scholar
• Hauben D J., Zirkin H, Mahler D, et al. The biologic behaviour of basal cell carcinoma: analysis of recurrence in excised basal cell carcinoma: part II. Plast Reconstr Surg 1982; 69: 110–16
   PubMed Web of Science ®Google Scholar
• Torres A, Seeburger J, Robison D, et al. The reliability of second biopsy for determining residual tumor. J Am Acad Dermatol 1992; 27: 70–3
   PubMed Web of Science ®Google Scholar
• Paterson D A., Davies J D., McLaren K M. Failure to demonstrate the true resection margins of excised skin tumours: a case for routine marking. Br J Dermatol 1992; 127: 119–21
   PubMed Web of Science ®Google Scholar
• Richmond J D., Davie R M. The significance of incomplete excision in patients with basal cell carcinoma. Br J Plast Surg 1987; 40: 63–7
   PubMedGoogle Scholar
• Swanson N A. Mohs surgery: technique, indications, applications and the future. Arch Dermatol 1983; 119: 761–73
   PubMedGoogle Scholar
• Fenton O. Disagreement over the use of Mohs chemosurgery. Br J Hosp Med 1993; 50: 351
   PubMed Web of Science ®Google Scholar
• Perks A GB. Management of extensive facial basal cell carcinoma by excision and microvascular tissue transfer. Ann R Coll Surg Engl 1994; 76: 287
   PubMed Web of Science ®Google Scholar
• Dzubow L M. Mohs surgery. Lancet 1994; 343: 433–4
   PubMed Web of Science ®Google Scholar
• Tromovitch T A., Stegman S J. Microscopic-controlled excision of cutaneous tumours. Cancer 1978; 41: 653–8
   PubMed Web of Science ®Google Scholar
• Cottel W I., Proper S. Mohs' surgery, fresh-tissue technique. J Dermatol Surg Oncol 1982; 8: 576–87
   PubMedGoogle Scholar
• Picoto A M., Picoto A. Technical procedures for Mohs fresh tissue surgery. J Dermatol Surg Oncol 1986; 12: 134–8
   PubMedGoogle Scholar
• Miller L J., Argenyi Z B., Whitaker D C. The preparation of frozen sections for micrographic surgery. J Dermatol Surg Oncol 1993; 19: 1023–9
   PubMedGoogle Scholar
• Motley R J., Holt P JA. A simple device for optimal tissue preparation for Mohs micrographic surgery. Br J Dermatol 1992; 126: 57–9
   PubMed Web of Science ®Google Scholar
• Edens B L., Bartlow G A., Haghghi P, et al. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma. J Am Acad Dermatol 1983; 9: 383–8
   PubMed Web of Science ®Google Scholar
• Suhge d' Aubermont P C., Bennett R G. Failure of curettage and electrodesiccation in the removal of basal cell carcinoma. Arch Dermatol 1984; 120: 1456–60
   PubMedGoogle Scholar
• Goldschmidt H, Breneman J C., Breneman D L. Ionising radiation therapy in dermatology. J Am Acad Dermatol 1994; 30: 157–82
   PubMed Web of Science ®Google Scholar
• Holt P JA. Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol 1988; 119: 231–40
   PubMed Web of Science ®Google Scholar
• Gunnarson G, Larko O, Hersle K. Cryosurgery of eyelid basal cell carcinomas. Acta Ophthalmol 1990; 68: 241–5
   Web of Science ®Google Scholar
• Cornell R C., Greenway H T., Tucker S B., et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23: 694–700
   PubMed Web of Science ®Google Scholar
• Stenquist B, Wennberg A M., Gisslen H, et al. Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery. J Am Acad Dermatol 1992; 27: 65–9
   PubMed Web of Science ®Google Scholar
• Epstein E. Intralesional therapy for basal cell carcinoma. J Am Acad Dermatol 1992; 26: 142–3
   PubMed Web of Science ®Google Scholar
• Orenberg E K., Miller B H., Greenway H T., et al. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma. J Am Acad Dermatol 1992; 27: 723–8
   PubMed Web of Science ®Google Scholar
• Baxter D L., Joyce Plummer A., Feldman B D., et al. Cisplatin chemotherapy for basal cell carcinoma: the need for post treatment biopsy-report of a case. J Am Acad Dermatol 1990; 23: 1167–8
   PubMed Web of Science ®Google Scholar
• Wilson B D., Mang T S., Stoll H, et al. Photodynamic therapy for treatment of basal cell carcinoma. Arch Dermatol 1992; 128: 1597–601
   PubMedGoogle Scholar
• Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 1993; 28: 17–21
   PubMed Web of Science ®Google Scholar
• Silverman M K., Kopf A W., Grin C M., et al. Recurrence rates of treated basal cell carcinoma. J Dermatol Surg Oncol 1991; 17: 713–18
   PubMedGoogle Scholar
• Lawrence C M. Mohs surgery of basal cell carcinoma-a critical review. Br J Plast Surg 1993; 46: 599–606
   PubMedGoogle Scholar